Amgen’s New Enbrel Patent May Undercut Health Care Plan
Wednesday, November 23, 2011 - 10:10
in Health & Medicine
The extra patent protection of the profitable drug Enbrel, a rheumatoid arthritis and psoriasis treatment, could keep a cheaper version off the market until 2028.